Publication of the start of coverage survey drafted by Mediobanca; declaring a target price at €24.50. PharmaNutra S.p.A. has […]
International recognition continues for PharmaNutra, which, whilst commercially experiencing a strong and constant expansion in foreign markets, also continues, from […]
Sorry, this entry is only available in Italian. Con il suo brand Cetilar®, PharmaNutra affiancherà per il primo anno il […]
The Group obtains approval of two new patents for the Sucrosomial® Technology and signs a distribution agreement for the SiderAL® […]
The new patent, valid until 2037, opens PharmaNutra up to the possibility of developing specific products for the cardiovascular field, […]
CPhI Worldwide 2019 was held from 5ᵗʰ to 7ᵗʰ November: three days dedicated to the best of global pharma, during […]